Literature DB >> 8132742

Leukotriene A4 hydrolase in human bronchoalveolar lavage fluid.

D A Munafo1, K Shindo, J R Baker, T D Bigby.   

Abstract

We examined cell-free human bronchoalveolar lavage fluid (BALF) for enzymes of the 5-lipoxygenase pathway. BALF was obtained from six patients who were active smokers and six nonsmokers. Enzymatic activity in cell-free BALF was assessed by specific assays for leukotriene (LT) A4 hydrolase, 5-lipoxygenase, and LTC4 synthase using HPLC. Only LTA4 hydrolase enzymatic activity was found. This activity ranged from 101 to 667 when expressed as picomoles of LTB4 produced per milliliter BALF. Enzymatic activity in smokers vs nonsmokers was 484 +/- 120 vs 129 +/- 32 pmol LTB4/ml BALF (mean +/- SD, P < 0.0001). There were no leukotrienes found in BALF before assay. Immunoblot analysis revealed an immunoreactive band at a relative molecular mass of 69,000 D in all samples, consistent with LTA4 hydrolase, but no evidence of 5-lipoxygenase. BALF had greater LTA4 hydrolase activity per milligram of protein than neutrophil cytosol, epithelial cell cytosol, plasma, or serum. The synthesis of LTB4 was significantly increased when neutrophils were stimulated in BALF. These data indicate the selective presence of LTA4 hydrolase in BALF which is significantly increased in smokers. This enzyme in BALF may contribute to the inflammatory response in tobacco-related lung disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132742      PMCID: PMC294032          DOI: 10.1172/JCI117053

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Transcellular metabolism of neutrophil-derived leukotriene A4 by human platelets. A potential cellular source of leukotriene C4.

Authors:  J A Maclouf; R C Murphy
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

2.  Studies on the regulation, biosynthesis, and activation of 5-lipoxygenase in differentiated HL60 cells.

Authors:  S Kargman; C A Rouzer
Journal:  J Biol Chem       Date:  1989-08-05       Impact factor: 5.157

3.  Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187.

Authors:  C A Rouzer; S Kargman
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

4.  Release of leukotrienes in patients with bronchial asthma.

Authors:  S Lam; H Chan; J C LeRiche; M Chan-Yeung; H Salari
Journal:  J Allergy Clin Immunol       Date:  1988-04       Impact factor: 10.793

5.  Leukotriene A4 hydrolase in the human lung. Inactivation of the enzyme with leukotriene A4 isomers.

Authors:  N Ohishi; T Izumi; M Minami; S Kitamura; Y Seyama; S Ohkawa; S Terao; H Yotsumoto; F Takaku; T Shimizu
Journal:  J Biol Chem       Date:  1987-07-25       Impact factor: 5.157

6.  Endothelial cell leukotriene C4 synthesis results from intercellular transfer of leukotriene A4 synthesized by polymorphonuclear leukocytes.

Authors:  S J Feinmark; P J Cannon
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

7.  Phospholipid bilayers enhance the stability of leukotriene A4 and epoxytetraenes: stabilization of eicosanoids by liposomes.

Authors:  S Fiore; C N Serhan
Journal:  Biochem Biophys Res Commun       Date:  1989-03-15       Impact factor: 3.575

8.  Increased concentrations of leukotrienes in bronchoalveolar lavage fluid of patients with ARDS or at risk for ARDS.

Authors:  A H Stephenson; A J Lonigro; T M Hyers; R O Webster; A A Fowler
Journal:  Am Rev Respir Dis       Date:  1988-09

9.  Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zinc-metallohydrolases.

Authors:  B Malfroy; H Kado-Fong; C Gros; B Giros; J C Schwartz; R Hellmiss
Journal:  Biochem Biophys Res Commun       Date:  1989-05-30       Impact factor: 3.575

10.  Detection of leukotrienes B4, C4 and of their isomers in arterial, mixed venous blood and bronchoalveolar lavage fluid from ARDS patients.

Authors:  M Antonelli; M Bufi; R A De Blasi; G Crimi; G Conti; C Mattia; G Vivino; L Lenti; D Lombardi; A Dotta
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

View more
  7 in total

Review 1.  Leukotriene A4 hydrolase and the committed step in leukotriene B4 biosynthesis.

Authors:  J Z Haeggström
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

2.  Lymphocytes stimulate expression of 5-lipoxygenase and its activating protein in monocytes in vitro via granulocyte macrophage colony-stimulating factor and interleukin 3.

Authors:  W L Ring; C A Riddick; J R Baker; D A Munafo; T D Bigby
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

3.  LTA4 hydrolase in human skin: decreased activity, but normal concentration in lesional psoriatic skin. Evidence for different LTA4 hydrolase activity in human lymphocytes and human skin.

Authors:  L Iversen; B Deleuran; A M Hoberg; K Kragballe
Journal:  Arch Dermatol Res       Date:  1996-05       Impact factor: 3.017

4.  Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor.

Authors:  K Shindo; K Koide; M Fukumura
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

5.  A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation.

Authors:  Robert J Snelgrove; Patricia L Jackson; Matthew T Hardison; Brett D Noerager; Andrew Kinloch; Amit Gaggar; Suresh Shastry; Steven M Rowe; Yun M Shim; Tracy Hussell; J Edwin Blalock
Journal:  Science       Date:  2010-09-02       Impact factor: 47.728

6.  Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness.

Authors:  Bruce D Levy; Payal Kohli; Katherine Gotlinger; Oliver Haworth; Song Hong; Shamsah Kazani; Elliot Israel; Kathleen J Haley; Charles N Serhan
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

7.  The interrelationship between leukotriene B4 and leukotriene-A4-hydrolase in collagen/adjuvant-induced arthritis in rats.

Authors:  Mariana Trivilin Mendes; Paulo Flavio Silveira
Journal:  Biomed Res Int       Date:  2014-02-20       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.